The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Aβ accumulation
Open accessAbstract
Although deficiencies in the retromer sorting pathway have been linked to late-onset Alzheimer's disease, whether these deficiencies underlie the disease remains unknown. Here we characterized two genetically modified animal models to test separate but related questions about the effects that retromer deficiency has on the brain. First, testing for cognitive defects, we investigated retromer-deficient mice and found that they develop hippocampal-dependent memory and synaptic dysfunction, which was associated with elevations in endogenous Aβ peptide. Second, testing for neurodegeneration and amyloid deposits, we investigated retromer-deficient flies expressing human wild-type amyloid precursor protein (APP) and human β-site APP-cleaving enzyme (BACE) and found that they develop neuronal loss and human Aβ aggregates. By recapitulating features of the disease, these animal models suggest that retromer deficiency observed in late-onset Alzheimer's disease can contribute to disease pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have demonstrated that VPS35 deficiency specifically increases β-cleavage of APP, which is primarily thought to be driven by the reduced trafficking of APP away from endosomes, resulting in increased exposure to BACE1 cleavage [135].”
From Global identification of neuronal and astrocytic integral membrane proteins that require Retromer for their endosomal recycling (2026) · cites this paper as [135]
In the citing paper
“VPS26 haploinsufficiency in mice have been shown to elevate amyloidogenic APP processing, Aβ accumulation, and induce synaptic defects (Muhammad, Flores et al. 2008), and pharmacological stabilization of the retromer complex can attenuate amyloidogenic APP processing in primary cultured mouse neurons (Mecozzi, Berman et al. 2014).”
From SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain (2026) · cites this paper as Muhammad, Flores et al. 2008
In the citing paper
“Moreover, VPS26 heterozygote mice show increased levels of endogenous Aβ and impaired LTP (Muhammad et al., 2008).”
From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Muhammad et al., 2008
In the citing paper
“The involvement of this pathway in Alzheimer disease was experimentally validated146.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [146]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
Brand, A. H., & Perrimon, N. (1993) · Development · doi:10.1242/dev.118.2.401 · Cited by 9,510
Genome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
Evolution of the neuropathology of Alzheimer's disease
Braak, H., & Braak, E. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05866.x · Cited by 710
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709
Self-citationAndersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A. F., Breiderhoff, T., Jansen, P., Wu, X., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503689102 · Cited by 655
Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer
Seaman, M. N. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312034 · Cited by 624
Flagged first, then by citations
1 of the 39 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- 10.1042/BST0331096 · DOI
- CP Perkins Further characterization of the murine embryonic lethal mutant Hb58 and its role in the visceral yolk sac. (Columbia University New York PhD dissertation. (1993).
Cited by
Sorted by citations
Items 201–248 of 248
Fu, C., Yang, N., Chuang, J.-Z., Nakajima, N., Iraha, S., Roy, N. S., Wu, Z., Jiang, Z., Otsu, W., Radu, R. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50189-0 · Cited by 9
Mechanisms regulating the sorting of soluble lysosomal proteins
Meraş, İ., Maes, J., & Lefrançois, S. (2022) · Bioscience Reports · doi:10.1042/bsr20211856 · Cited by 9
Beware of Misdelivery: Multifaceted Role of Retromer Transport in Neurodegenerative Diseases
Yoshida, S., & Hasegawa, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.897688 · Cited by 8
Cargo trafficking in Alzheimer’s disease: the possible role of retromer
Sadigh‐Eteghad, S., Askari-Nejad, M. S., Mahmoudi, J., & Majdi, A. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2399-3 · Cited by 8
P., N. N. V., Sundararajan, V., Dan, P., Venkatasubbu, G. D., & Mohideen, S. S. (2021) · Biocell · doi:10.32604/biocell.2021.015090 · Cited by 7
FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans
Kulkarni, R., Kasani, S. K., Tsai, C., Tung, S., Yeh, K., Yu, C.-H. A., & Chang, W. (2023) · Life Science Alliance · doi:10.26508/lsa.202201414 · Cited by 6
Depletion of ESCRT ameliorates APP‐induced AD‐like symptoms in Drosophila
Zhuang, L., Li, C., Peng, F., Xue, E., Li, W., Sun, X., Chen, P., Zhou, Q., & Xue, L. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31035 · Cited by 6
Bharathi, V., Zeng, Y., Armour, E. M., Yue, M., Citrano, K., Lovchykova, A., Reeves, M. M., Rawlinson, B. D., Deture, M. A., Dunmore, J. A., et al. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003573 · Cited by 5
Self-citationA Novel Neuroprotection Target With Distinct Regulation in Stroke and Alzheimer’s Disease
Gamir-Morralla, A., López‐Menéndez, C., Medina, M., & Iglesias, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00007-7 · Cited by 5
The role of membrane trafficking and retromer complex in Parkinson's and Alzheimer's disease
Abdul‐Rahman, T., Ghosh, S., Kalmanovich, J. B., Awuah, W. A., Zivcevska, M., Khalifa, S., Bassey, E. E., Ali, N. A., Ferreira, M. M. D. S., Umar, T. P., et al. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25261 · Cited by 4
Li, J.-G., Blass, B. E., & Praticò, D. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220869 · Cited by 4
Walsh, R. B., Becalska, A. N., Zunitch, M. J., Lemos, T., Dresselhaus, E. C., Lee, S. M., Wang, S., Isaac, B., Yeh, A., Koles, K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/645713 · Cited by 4
Schmelter, C., Fomo, K. N., Brueck, A., Perumal, N., Markowitsch, S. D., Govind, G., Speck, T., Pfeiffer, N., & Grus, F. H. (2023) · Biomolecules · doi:10.3390/biom13071161 · Cited by 3
Nadiminti, S. S. P., Kamak, M., & Koushika, S. P. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0961-5 · Cited by 3
Zhang, Y., Wu, Y., Zhang, X., Guo, S., He, J., Hu, N., Huang, Y., Kong, Y., Li, Q., Sui, A., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70124 · Cited by 2
Zebardast, F., Riethmueller, M. P. S., & Nowick, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-30392-9 · Cited by 2
Associations of sorLA/SORL1 with Alzheimer's disease
Andersen, O. M., & Thakurta, I. G. (2015) · Receptors & Clinical Investigation · doi:10.14800/rci.700 · Cited by 3
Re-mention of an old neurodegenerative disease: Alzheimer’s disease
Zhang, P., Adams, U., & Yuan, Z. (2013) · Chinese Science Bulletin · doi:10.1007/s11434-013-5673-x · Cited by 2
Sorting receptors at Down's syndrome synapses
Jones, M. W. (2013) · Nature Medicine · doi:10.1038/nm.3152 · Cited by 2
SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain
Huang, H., Shi, C. H., Yang, W., Piña-Crespo, J. C., Bhatnagar, J., Curatolo, J., Murad, R., Shah, P., Campos, A., Houser, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed6825 · Cited by 1
Cryo-EM structure of the WDR11-FAM91A1-C17orf75 complex involved in retrograde trafficking
Zhang, Y., Liu, Z., Chen, Z., Tang, X., Chen, Z., & Ding, J. (2026) · Structure · doi:10.1016/j.str.2026.07.011 · Cited by 1
Quantitative Analysis of Retromer Complex-Related Genes during Embryo Development in the Mouse
Park, S.-J., Huh, J., Kim, Y., Kim, J.-S., Song, B., Lee, S., Kim, S.-U., Kim, H., Imakawa, K., & Chang, K. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0272-7 · Cited by 1
Notch Signaling: From Neurogenesis to Neurodegeneration
Sachan, N., Mutsuddi, M., & Mukherjee, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-2218-1_7 · Cited by 1
γ-secretase facilitates retromer-mediated retrograde transport
Takeo, Y., Crite, M., Mehmood, K., & DiMaio, D. (2025) · Journal of Cell Science · doi:10.1242/jcs.263538 · Cited by 1
Diabetes-Associated Gene is Found to Regulate Alzheimer Disease Amyloid Metabolism
Talan, J. (2010) · Neurology Today · doi:10.1097/01.nt.0000390838.19594.b2 · Cited by 1
Understanding Neurodegeneration and Neuroprotection Through Genetic Screens in Drosophila
Mandya, A. S., Cheramangalam, R. N., & Jaiswal, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-2218-1_3 · Cited by 1
Seaman, M. N. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.20048-5 · Cited by 1
Identification and characterization of full-length vps29 gene in five mammalian species
Kim, Y., Park, S.-J., Huh, J., Kim, K.-M., Lee, S., Imakawa, K., & Chang, K. (2011) · Genes & Genomics · doi:10.1007/s13258-011-0066-5
Retrograde transport- the journey back to Golgi
Banerjee, A. (2012) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-0440104
Sorting Nexin 27 Regulates Ab Production through Modulating g-Secretase Activity
Wang, X., Huang, T. Y., Hong, W., & Xu, H. (2014)
The role of phosphatidylinositol 3-kinases in autophagy regulation
Devereaux, K. A. (2014) · doi:10.7916/d8qz2842
The endolysosomal system in neuronal physiology and pathology
Sanchez, S. V. (2019)
Kim, E. (2020) · JoLS Journal of Life Sciences · doi:10.5352/jls.2020.30.8.708
The Immune Response in Parkinson's Disease
Lira, A. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3524
Seaman, M. N. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00054-7
Molecular Investigation of Protein–Protein Interaction Candidates Related to the Mammalian Brain
(2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166037-00081
Trafficking of Muscarinic 1 Acetylcholine Receptor Regulated by VPS35 in Alzheimer's Disease
Wang, C., Chen, X., & Yu, Z. (2025) · Current Alzheimer Research · doi:10.2174/0115672050356990250111200217
Chavis, G. D., Rivero-Ríos, P., Uygun, T., Tsukahara, T., Hayami, T., Lee, G. Y., Lee, M., Pace, C., Czesak, F. N., Hilde, K. L., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.11.009
Post, W. M., Widomska, J., Oosterwijk, E., Witte, W. D., Tiemessen, D. M., Klemann, C. J. H. M., Ruisch, I. H., Coenen, M. J. H., Janssen, D. A. W., Martens, F. M. J., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146156
Retromer-targeted therapy for neurodegenerative diseases
Persico, M., Tuithung, S., Lorenzo, A., Crawford, D., Eleuteri, S., & Simon, D. K. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00971-z
Zeng, Y., Wei, S., Hu, K., Zhao, R., Yu, S., Yu, T., Huang, B., Duan, L., & Zhao, X. (2026) · Biomedicines · doi:10.3390/biomedicines14102293
Liu, Z., Lee, D., Tan, Z., Wu, A., Mei, L., & Xiong, W. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00585-x
Jones, E., Adams, H., Chen, K.-E., Maroof, F., Ibbotson, T. M., Nakamura, Y., Banks, P. J., Healy, M. D., Lewis, P. A., Heesom, K. J., et al. (2026) · doi:10.64898/2026.05.14.724903
Metadata
- Authors
- Muhammad, A., Flores, I., Zhang, H., Yu, R., Staniszewski, A., Planel, E., Herman, M., Ho, L., Kreber, R., Honig, L. S., Ganetzky, B., Duff, K., Arancio, O., & Small, S. A.
- Affiliations
- Columbia University Irving Medical Center (US)
- *Taub Institute for Research on Alzheimer's Disease and the Aging Brain, and
- University of Wisconsin–Madison (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-05-20
- Volume
- 105
- Issue
- 20
- Pages
- 7327-7332
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2386077
- OpenAlex
- W2049746112
- Cited by
- 248
- References
- 39
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 6 · 2023: 11 · 2022: 11 · 2021: 10 · 2020: 11 · 2019: 10 · 2018: 17 · 2017: 19 · 2016: 21 · 2015: 19 · 2014: 22 · 2013: 18 · 2012: 19
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG172116, AG025161, R01AG025161, P50AG008702)
- National Institute of Neurological Disorders and Stroke (NS48447, P01NS048447, R01NS049442, R01NS015390, NS015390, NS049442)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- retromer complex, Alzheimer's disease, late-onset Alzheimer's disease, hippocampal-dependent memory, synaptic dysfunction, amyloid-beta deposition, amyloid precursor protein, neurodegeneration, neuronal loss, Drosophila model
- MeSH terms
- Alzheimer Disease, Animals, Brain, Disease Models, Animal, Drosophila, Electrophysiology, Heterozygote, Hippocampus, Humans, Models, Biological, Amyloid beta-Peptides, Mice, Knockout, Neurodegenerative Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
